These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19142705)

  • 1. Validation of fast-RAMLA in clinical PET.
    Sato H; Cho K; Fukushima Y; Shiiba M; Hakozaki K; Kiriyama T; Sakurai M; Kanaya K; Kumita S
    Ann Nucl Med; 2008 Dec; 22(10):869-76. PubMed ID: 19142705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of variation in relaxation parameter value on LOR-RAMLA reconstruction of 18F-FDG PET studies.
    Groheux D; Martineau A; Vrigneaud JM; Hindie E; Baillet G; Moretti JL
    Nucl Med Commun; 2009 Dec; 30(12):926-33. PubMed ID: 19574939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical validation of fully 3-D versus 2.5-D RAMLA reconstruction on the Philips-ADAC CPET PET scanner.
    Chiang S; Cardi C; Matej S; Zhuang H; Newberg A; Alavi A; Karp JS
    Nucl Med Commun; 2004 Nov; 25(11):1103-7. PubMed ID: 15577588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of PET image reconstruction using a spatial resolution model.
    Andersen FL; Klausen TL; Loft A; Beyer T; Holm S
    Eur J Radiol; 2013 May; 82(5):862-9. PubMed ID: 23254158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients.
    Schöder H; Erdi YE; Chao K; Gonen M; Larson SM; Yeung HW
    J Nucl Med; 2004 Apr; 45(4):559-66. PubMed ID: 15073250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
    Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR
    Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
    Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
    J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner.
    Lodge MA; Badawi RD; Gilbert R; Dibos PE; Line BR
    J Nucl Med; 2006 Jan; 47(1):23-31. PubMed ID: 16391183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does partial volume corrected maximum SUV based on count recovery coefficient in 3D-PET/CT correlate with clinical aggressiveness of non-Hodgkin's lymphoma?
    Tsujikawa T; Otsuka H; Morita N; Saegusa H; Kobayashi M; Okazawa H; Nishitani H
    Ann Nucl Med; 2008 Jan; 22(1):23-30. PubMed ID: 18250984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depiction and characterization of liver lesions in whole body [¹⁸F]-FDG PET/MRI.
    Beiderwellen K; Gomez B; Buchbender C; Hartung V; Poeppel TD; Nensa F; Kuehl H; Bockisch A; Lauenstein TC
    Eur J Radiol; 2013 Nov; 82(11):e669-75. PubMed ID: 24011443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
    Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
    AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy.
    Conrad GR; Sinha P
    Nucl Med Commun; 2003 Nov; 24(11):1129-37. PubMed ID: 14569166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in lesion detection with whole-body oncologic time-of-flight PET.
    El Fakhri G; Surti S; Trott CM; Scheuermann J; Karp JS
    J Nucl Med; 2011 Mar; 52(3):347-53. PubMed ID: 21321265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lesion detection observer study comparing 2-dimensional versus fully 3-dimensional whole-body PET imaging protocols.
    Lartizien C; Kinahan PE; Comtat C
    J Nucl Med; 2004 Apr; 45(4):714-23. PubMed ID: 15073270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET of common enhancing malignant brain tumors.
    Kosaka N; Tsuchida T; Uematsu H; Kimura H; Okazawa H; Itoh H
    AJR Am J Roentgenol; 2008 Jun; 190(6):W365-9. PubMed ID: 18492879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study.
    Akamatsu G; Ikari Y; Nishida H; Nishio T; Ohnishi A; Maebatake A; Sasaki M; Senda M
    J Nucl Med Technol; 2015 Sep; 43(3):222-6. PubMed ID: 26271802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.
    Beyer T; Bockisch A; Kühl H; Martinez MJ
    J Nucl Med; 2006 Jan; 47(1):91-9. PubMed ID: 16391192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual time point 2-[18F]fluoro-2'-deoxyglucose positron emission tomography in chronic bacterial osteomyelitis.
    Sahlmann CO; Siefker U; Lehmann K; Meller J
    Nucl Med Commun; 2004 Aug; 25(8):819-23. PubMed ID: 15266177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A region growing method for tumor volume segmentation on PET images for rectal and anal cancer patients.
    Day E; Betler J; Parda D; Reitz B; Kirichenko A; Mohammadi S; Miften M
    Med Phys; 2009 Oct; 36(10):4349-58. PubMed ID: 19928065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
    Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
    Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.